Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OxyContin ANDA Approval Delay Requested By Purdue In Petition To FDA

Jan 12 2004

• By The Pink Sheet

Related Content

OxyContin Patents Invalid Due To Purdue’s Inequitable Conduct, Court Says

Jan 12 2004

Mylan Generic Isotretinoin Price Will Be 90% Of Roche Accutane AWP

Nov 18 2002

Accutane Generics Need Separate Risk Management Programs, Roche Says

Feb 18 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window